API

Current Product List

Products
<img src="https://smspharma.com/wp-content/uploads/2022/08/p-logo-1.jpg" style="vertical-align: middle;border:1px solid #103866;" />
<img src="https://smspharma.com/wp-content/uploads/2022/08/p-logo-2.jpg" style="vertical-align: middle;border:1px solid #103866;" />
<img src="https://smspharma.com/wp-content/uploads/2022/08/p-logo-3.jpg" style="vertical-align: middle;border:1px solid #103866;" />
<img src="https://smspharma.com/wp-content/uploads/2022/08/p-logo-4.jpg" style="vertical-align: middle;border:1px solid #103866;" />
<img src="https://smspharma.com/wp-content/uploads/2022/08/p-logo-5.jpg" style="vertical-align: middle;border:1px solid #103866;" />
<img src="https://smspharma.com/wp-content/uploads/2022/08/p-logo-6.jpg" style="vertical-align: middle;border:1px solid #103866;" />
<img src="https://smspharma.com/wp-content/uploads/2022/08/p-logo-7.jpg" style="vertical-align: middle;border:1px solid #103866;" />
<h4>Anti-Ulcer</h4>
Famotidine
<h4>Anti-Fungal</h4>
Itraconazole 
<h4>Anti-Migrane</h4>
Sumatriptan Succinate(AS)
Sumatriptan Base
Almotriptan Malate
Zolmitriptan
Rizatriptan Benzoate 
Eletriptan Hydrobromide Monohydrate
<h4>Erectile Dysfunction</h4>
Sildenafil Citrate 
Tadalafil
<h4>Anti-Emetic</h4>
Ondansetron HCL
Imidapril Hcl
Products
USFDA
CEP-EU
Health Canada
PMDA
KFDA
TGA
ROW
<b>Anti-Ulcer</b>
Famotidine
<b>Anti-Fungal</b>
Itraconazole 
<b>Anti-Migrane</b>
Sumatriptan Succinate(AS)
Sumatriptan Base
Almotriptan Malate
Zolmitriptan
Rizatriptan Benzoate 
Eletriptan Hydrobromide Monohydrate
<b>Erectile Dysfunction</b>
Sildenafil Citrate 
Tadalafil
<b>Anti-Emetic</b>
Ondansetron HCL
Imidapril Hcl
Note:- Some of the products may have patent rights in one or more countries and any such product having an existing patent will not be offered/sold for commercial requirements. The final responsibility with respect to third party patent rights lies exclusively with the buyer.

For specific information on the products, API and other avenues for partnerships,
contact [email protected]

Enquiry Form

INVESTORS DESK